Eleni D. Lagadinou

1.8k total citations · 1 hit paper
11 papers, 1.1k citations indexed

About

Eleni D. Lagadinou is a scholar working on Hematology, Molecular Biology and Epidemiology. According to data from OpenAlex, Eleni D. Lagadinou has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Eleni D. Lagadinou's work include Acute Myeloid Leukemia Research (4 papers), Histone Deacetylase Inhibitors Research (2 papers) and Protein Degradation and Inhibitors (2 papers). Eleni D. Lagadinou is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Histone Deacetylase Inhibitors Research (2 papers) and Protein Degradation and Inhibitors (2 papers). Eleni D. Lagadinou collaborates with scholars based in Greece, United States and Germany. Eleni D. Lagadinou's co-authors include Jane L. Liesveld, Kevin P. Callahan, Michael W. Becker, Craig T. Jordan, Mohammad Minhajuddin, Valerie Grose, Kristen M. O’Dwyer, Randall M. Rossi, Shanshan Pei and Sarah J. Neering and has published in prestigious journals such as Blood, Cell stem cell and Leukemia.

In The Last Decade

Eleni D. Lagadinou

11 papers receiving 1.1k citations

Hit Papers

BCL-2 Inhibition Targets Oxidative Phosphorylation and Se... 2013 2026 2017 2021 2013 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
    2013 943 citations Eleni D. Lagadinou, Kevin P. Callahan et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eleni D. Lagadinou Greece 7 764 550 315 222 131 11 1.1k
Valerie Grose United States 6 848 1.1× 495 0.9× 374 1.2× 246 1.1× 137 1.0× 11 1.3k
Nabilah Khan United States 9 892 1.2× 703 1.3× 458 1.5× 168 0.8× 151 1.2× 17 1.3k
Karen Dunn United Kingdom 13 801 1.0× 510 0.9× 275 0.9× 180 0.8× 207 1.6× 29 1.4k
S. Haihua Chu United States 18 863 1.1× 438 0.8× 151 0.5× 113 0.5× 181 1.4× 32 1.2k
Clément Larrue France 14 525 0.7× 380 0.7× 173 0.5× 135 0.6× 96 0.7× 23 788
Pablo Baquero Spain 12 620 0.8× 316 0.6× 246 0.8× 188 0.8× 52 0.4× 17 959
Shenmeng Gao China 21 894 1.2× 173 0.3× 572 1.8× 154 0.7× 101 0.8× 49 1.2k
Alan Burnett United Kingdom 8 977 1.3× 856 1.6× 146 0.5× 165 0.7× 132 1.0× 14 1.4k
Haley E. Ramsey United States 17 464 0.6× 335 0.6× 96 0.3× 117 0.5× 149 1.1× 36 798
Magdalena Plašilová United States 12 372 0.5× 329 0.6× 154 0.5× 202 0.9× 313 2.4× 17 945

Countries citing papers authored by Eleni D. Lagadinou

Since Specialization
Citations

This map shows the geographic impact of Eleni D. Lagadinou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleni D. Lagadinou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleni D. Lagadinou more than expected).

Fields of papers citing papers by Eleni D. Lagadinou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleni D. Lagadinou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleni D. Lagadinou. The network helps show where Eleni D. Lagadinou may publish in the future.

Co-authorship network of co-authors of Eleni D. Lagadinou

This figure shows the co-authorship network connecting the top 25 collaborators of Eleni D. Lagadinou. A scholar is included among the top collaborators of Eleni D. Lagadinou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleni D. Lagadinou. Eleni D. Lagadinou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Callahan, Kevin P., Mohammad Minhajuddin, Cheryl A. Corbett, et al.. (2014). Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity. Leukemia. 28(10). 1960–1968. 31 indexed citations
2.
Lagadinou, Eleni D., Kevin P. Callahan, Randall M. Rossi, et al.. (2013). BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells. Cell stem cell. 12(3). 329–341. 943 indexed citations breakdown →
3.
Lagadinou, Eleni D., Kevin P. Callahan, Randall M. Rossi, et al.. (2012). Bcl-2 Inhibitor ABT-263 Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells. Blood. 120(21). 206–206. 3 indexed citations
4.
Minhajuddin, Mohammad, Shanshan Pei, John M. Ashton, et al.. (2011). Molecular Mechanisms of Parthenolide-Mediated Pro-Apoptotic Activity in Acute Myeloid Leukemia Cells. Blood. 118(21). 2463–2463. 1 indexed citations
5.
Lagadinou, Eleni D., Kevin P. Callahan, Sarah J. Neering, et al.. (2011). Reactive Oxygen Species (ROS) Levels Define Functional Heterogeneity in Human Leukemia Stem Cells and Represent a Critical Parameter for Therapeutic Targeting. Blood. 118(21). 639–639. 1 indexed citations
6.
7.
Lagadinou, Eleni D., Markos Marangos, Maria Liga, et al.. (2010). Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet. Transplant Infectious Disease. 12(5). 437–440. 20 indexed citations
8.
9.
Ziros, Panos G., Eleni D. Lagadinou, Argiris Symeonidis, et al.. (2009). Disease-Related Anemia in Chronic Lymphocytic Leukemia Is Not Due to Intrinsic Defects of Erythroid Precursors: A Possible Pathogenetic Role for Tumor Necrosis Factor-Alpha. Acta Haematologica. 121(4). 187–195. 22 indexed citations
10.
Lagadinou, Eleni D., Panos G. Ziros, Μαρίνα Καρακάντζα, et al.. (2008). c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia. Leukemia. 22(10). 1899–1908. 31 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerie Grose Breakdown of academic impact, for papers by Nabilah Khan Breakdown of academic impact, for papers by Karen Dunn Breakdown of academic impact, for papers by S. Haihua Chu Breakdown of academic impact, for papers by Clément Larrue Breakdown of academic impact, for papers by Pablo Baquero Breakdown of academic impact, for papers by Shenmeng Gao Breakdown of academic impact, for papers by Alan Burnett Breakdown of academic impact, for papers by Haley E. Ramsey Breakdown of academic impact, for papers by Magdalena Plašilová
Rankless by CCL
2026